Login to Your Account

Taking it up a Notch: Nohla sets sights on universal cell therapy

By Jennifer Boggs
Managing Editor

Wednesday, April 13, 2016

Nohla Therapeutics Inc., a 2015 spin-off of the Fred Hutchinson Cancer Research Center, has a simply stated yet ambitious goal to create a “truly universal, off-the-shelf” ex vivo-expanded umbilical cord blood stem cell product.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription